Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 20, 2018

Study Completion Date

July 20, 2018

Conditions

Psoriasis

Interventions

OTHER

Dose decrease

Treatment strategy change: dose decrease based on PASI and DLQI

OTHER

Usual care

Trial Locations (6)

ZGT hospital, Almelo

Gelre hospitals, Apeldoorn

Slingeland Hospital, Doetinchem

St. Anna hospital, Geldrop

ZGT, Hengelo

Radboudumc, dept of dermatology, Nijmegen

All Listed Sponsors

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Radboud University Medical Center

OTHER

NCT02602925 - Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity | Biotech Hunter | Biotech Hunter